Approved by the Quality Standards Subcommittee on April 15, 2008; by the Therapeutics and Technology Assessment Subcommittee on December 17, 2007; by the Practice Committee on January 25, 2009; and by the AAN Board of Directors on March 25, 2009. This article is being published jointly/simultaneously by ILAE in Epilepsia and AAN in Neurology.
Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes
Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society
Article first published online: 27 APR 2009
Wiley Periodicals, Inc. © 2009 International League Against Epilepsy
Volume 50, Issue 5, pages 1237–1246, May 2009
How to Cite
Harden, C. L., Meador, K. J., Pennell, P. B., Allen Hauser, W., Gronseth, G. S., French, J. A., Wiebe, S., Thurman, D., Koppel, B. S., Kaplan, P. W., Robinson, J. N., Hopp, J., Ting, T. Y., Gidal, B., Hovinga, C. A., Wilner, A. N., Vazquez, B., Holmes, L., Krumholz, A., Finnell, R., Hirtz, D. and Le Guen, C. (2009), Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes. Epilepsia, 50: 1237–1246. doi: 10.1111/j.1528-1167.2009.02129.x
- Issue published online: 7 MAY 2009
- Article first published online: 27 APR 2009
- Accepted February 24, 2009; Early View publication April 27, 2009.
Appendix e-1a. Mission statement of QSS.
Appendix e-1b. Mission statement of TTA.
Appendix e-2. Conflict of interest statement.
Appendix e-3a. Quality standards subcommittee (QSS) Members.
Appendix e-3b. Therapeutics and technology assessment subcommittee members.
Appendix e-4a. Classification of evidence for causality.
Appendix e-4b. Classification of evidence for rating of a prognostic article.
Appendix e-5a. Classification of recommendations.
Appendix e-5b. Classification of recommendations for causality.
Table e-1. MCMs in the children of treated WWE.
Table e-2. Risks of MCMs for specific AEDs as compared to others.
Table e-3. MCM risks of polytherapy versus monotherapy.
Table e-4. AED dosage in first trimester and MCMs.
Table e-5. AED specific MCMs.
Table e-6. Teratogenesis of cognitive impairment in the offspring of WWE.
Table e-7. Adverse pregnancy outcomes.
Please note: Wiley-Blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.
|EPI_2129_sm_E-appendices_Tetatogenesis.doc||52K||Supporting info item|
|EPI_2129_sm_E-tables teratogenesis.doc||130K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.